Guarna; Antonio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guarna; Antonio.The latest application filed is for "compounds for the treatment of ischemia-reperfusion-related diseases".

Company Profile

0.13.13

Guarna; Antonio - Seravezza IT
Guarna; Antonio - Servezza N/A IT
Guarna; Antonio - Sesto Fiorentino IT
Guarna; Antonio - Serravezza N/A IT
Guarna; Antonio - Milano IT
Guarna; Antonio - Seano IT
Guarna; Antonio - Seano Carmignagno IT
Guarna; Antonio - Seano-Carmigiano IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For The Treatment Of Ischemia-reperfusion-related Diseases App 20180155363 - Guarna; Antonio ; et al.	2018-06-07
Compounds for the treatment of ischemia-reperfusion-related diseases Grant 9,932,352 - Guarna , et al. April 3, 2	2018-04-03
Compounds For The Treatment Of Ischemia-reperfusion-related Diseases App 20150080388 - Guarna; Antonio ; et al.	2015-03-19
Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allengenic diseases Grant 8,822,407 - Romagnani , et al. September 2, 2	2014-09-02
1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors Grant 8,809,338 - Guarna , et al. August 19, 2	2014-08-19
Preparation Of Conjugates Comprising Adenine Derivatives And Allergenic Proteins And Their Use For Specific Immunotherapy Of Allengenic Diseases App 20130136764 - Romagnani; Sergio ; et al.	2013-05-30
Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases Grant 8,445,484 - Cassone , et al. May 21, 2	2013-05-21
1,2,3-triazole-based Peptidomimetic Integrin Inhibitors For The Diagnosis And Therapy Of Tumors App 20130040964 - Guarna; Antonio ; et al.	2013-02-14
Process for the preparation of 2,3,4,9-tetrahydro-1H-.beta.-carbolin-3-carboxylic acid esters Grant 8,357,803 - Borzatta , et al. January 22, 2	2013-01-22
Bicyclic Peptidomimetic Inhibitors Of Aspartyl-proteases For The Treatment Of Infectious Diseases App 20110237577 - Cassone; Antonio ; et al.	2011-09-29
Process For The Preparation Of 2,3,4,9-tetrahydro-1h-beta-carbolin-3-carboxylic Acid Esters App 20100324294 - Borzatta; Valerio ; et al.	2010-12-23
Heterocylic Compounds Containing The Morpholine Nucleus Their Preparation And Use App 20100087326 - Guarna; Antonio ; et al.	2010-04-08
Pharmaceutical compositions for the treatment of diseases related to neurotrophines Grant 7,625,892 - Guarna , et al. December 1, 2	2009-12-01
Pharmaceutical compositions for the treatment of diseases related to neurotrophines App 20060069092 - Guarna; Antonio ; et al.	2006-03-30
Benzo(C)quinolizine derivatives and their use as 5.alpha.-reductases inhibitors Grant 6,962,925 - Guarna , et al. November 8, 2	2005-11-08
Process for the synthesis of (1-H)-benzo[c]quinolizin-3-ones derivatives Grant 6,723,850 - Guarna , et al. April 20, 2	2004-04-20
3-aza-6,8-dioxabicyclo [3.2.1] octanes and analogues and combinatorial libraries App 20030176414 - Guarna, Antonio ; et al.	2003-09-18
Use of benzo[C]quinolizine derivatives as plant growth regulators Grant 6,514,912 - Guarna , et al. February 4, 2	2003-02-04
Benzo[c]quinolizine derivatives, their preparation and use as 5alpha-reductases inhibitors App 20010047098 - Guarna, Antonio ; et al.	2001-11-29
Benzo [c] quinolizine derivatives, their preparation and use as 5alpha-reductases inhibitors App 20010044542 - Guarna, Antonio ; et al.	2001-11-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.